Literature DB >> 3764472

Mixed sclerosing bone dysplasia coexisting with dysplasia epiphysealis hemimelica (Trevor-Fairbank disease).

A Greenspan, G Steiner, D Sotelo, A Norman, A Sotelo, F Sotelo-Ortiz.   

Abstract

The coexistence of mixed sclerosing bone dysplasia and dysplasia epiphysealis hemimelica is a rare anomaly. This combination of abnormalities has not been previously reported. The clinical, radiographic, and pathologic features of this condition are discussed and the methods of treatment of articular complications are reviewed.

Entities:  

Mesh：

Year:  1986        PMID： 3764472     DOI： 10.1007/bf00355104

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN： 0364-2348            Impact factor:   2.199


  17 in total

1.  MIXED SCLEROSING BONE DYSTROPHIES. TWO CASE REPORTS.

Authors:  G F WALKER
Journal:  J Bone Joint Surg Br       Date:  1964-08

2.  Melorheostosis and osteopoikilosis, with a review of the literature.

Authors:  A E GREEN; W H ELLSWOOD; J R COLLINS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-06

3.  Osteopathia striata-Voorhoeve's disease; report of a case presenting the features of osteopathia striata and osteopetrosis.

Authors:  R L HURT
Journal:  J Bone Joint Surg Br       Date:  1953-02

4.  Osteopathia striata--Voorhoeve's disease. Review of the roentgen manifestations.

Authors:  J A Gehweiler; W R Bland; T S Carden; R H Daffner
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1973-06

5.  Familial dysplasia epiphysealis hemimelica, associated with chondromas and osteochondromas. Report of a kindred with variable presentations.

Authors:  R N Hensinger; H R Cowell; P L Ramsey; R G Leopold
Journal:  J Bone Joint Surg Am       Date:  1974-10       Impact factor: 5.284

6.  Melorheostosis. A report of the clinical, roentgenographic, and pathological findings in fourteen cases.

Authors:  C J Campbell; T Papademetriou; M Bonfiglio
Journal:  J Bone Joint Surg Am       Date:  1968-10       Impact factor: 5.284

7.  Disseminated asymptomatic osteosclerosis with features resembling melorheostosis, osteopoikilosis, and osteopathia striata. Case report.

Authors:  M N Abrahamson
Journal:  J Bone Joint Surg Am       Date:  1968-07       Impact factor: 5.284

8.  Osseous changes of osteopathia striata associated with cranial sclerosis. An autosomal dominant entity.

Authors:  P A Schnyder
Journal:  Skeletal Radiol       Date:  1980-02       Impact factor: 2.199

9.  Mixed-sclerosing-bone-dystrophy: report of a case and review of the literature.

Authors:  M P Whyte; W A Murphy; M D Fallon; T J Hahn
Journal:  Skeletal Radiol       Date:  1981       Impact factor: 2.199

10.  Melorheostosis and the sclerotomes: a radiological correlation.

Authors:  R O Murray; J McCredie
Journal:  Skeletal Radiol       Date:  1979-06-06       Impact factor: 2.199
View more
  5 in total

Review 1.  Sclerosing bone dysplasias--a target-site approach.

Authors:  A Greenspan
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

Review 2.  Mixed sclerosing bone dystrophy. Report of a case and review of the literature.

Authors:  J Belzunegui; I Plazaola; E Uriarte; C Gonzalez; M Figueroa
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

3.  Glenoid labrum ossification and mechanical restriction of joint motion: extraosseous manifestations of melorheostosis.

Authors:  N Subhas; M Sundaram; T W Bauer; W H Seitz; M P Recht
Journal:  Skeletal Radiol       Date:  2007-11-21       Impact factor: 2.199

4.  A Special Golden Curve in Human Upper Limbs' Length Proportion: A Functional Partition Which Is Different from Anatomy.

Authors:  Nan Wang; Jie Ma; Dan Jin; Bin Yu
Journal:  Biomed Res Int       Date:  2017-01-23       Impact factor: 3.411

Review 5.  Dysplasia epiphysealis hemimelica combined with contralateral accessory scaphoid bone: A case report and literature review.

Authors:  Bo Li; Jie Wen; Hong Liu; Sheng Xiao; Xin Li; Ke Fang; Ming Zeng; Zhongwen Tang; Shu Cao; Bo Lee; Fanling Li
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.